Interferon Signaling
基因
试剂
文献样例
产品评述样例
ARIH1
ariadne RBR E3 ubiquitin protein ligase 1
B2M
beta-2-microglobulin
总数:5
Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T-lymphocytes and preserved MHC class I antigen expression. 2008 至该文献
为了研究特定人群的肿瘤浸润淋巴细胞在诊断原发性黑色素瘤切片检查中的出现可以鉴定为临床阶段Ⅱ期黑色素瘤病人,采用了Dako的B2m的抗体进行了免疫组化实验。 更多
CAMK2A
calcium/calmodulin dependent protein kinase II alpha
总数:13
Requirement for Ca2+/calmodulin-dependent kinase II in the transition from pressure overload-induced cardiac hypertrophy to heart failure in mice. 2009 至该文献
为了研究CaMKII在调控血压过载诱导的小鼠心肌肥厚到心脏衰竭中的作用,采用了Affinity Bioreagents公司的抗磷酸化CaMKII抗体产品 ,进行了免疫印迹实验 更多
CAMK2G
calcium/calmodulin dependent protein kinase II gamma
总数:10
Novel insights into the mechanisms mediating the local antihypertrophic effects of cardiac atrial natriuretic peptide: role of cGMP-dependent protein kinase and RGS2. 2010 至该文献
为了研究cGMP依赖的蛋白激酶和RGS2在心钠素抵抗局部肥大中的作用,采用了Santa Cruz公司的抗磷酸化CaMKII抗体,进行western blot实验。 更多
CD44
CD44 molecule (Indian blood group)
总数:49
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1. 2013 至该文献
为了在小鼠模型中研究sFlt-1对于维持无血管感光层的作用,Millipore的大鼠抗硫酸肝素蛋白多糖单克隆抗体被用于进行免疫组化实验。 更多
CD56
neural cell adhesion molecule 1
总数:56
Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. 2012 至该文献
为了研究共生菌被先天淋巴细胞限定在特定的位置,采用了eBioscience的eFluor780标记的CD56抗体进行流式细胞分选实验。 更多
CD64
Fc fragment of IgG receptor Ia
总数:15
PPAR? controls Dectin-1 expression required for host antifungal defense against Candida albicans. 2010 至该文献
为了研究PPARgamm在调控dectin-1的表达和宿主抗真菌防御中的作用,采用了Serotec公司的抗F4/80抗体产品,进行了流式细胞分析实验。 更多
CIITA
class II major histocompatibility complex transactivator
总数:5
A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages. 2009 至该文献
为了研究JAK-STAT1通道在调控HSV-1复制中的作用,使用了Biolegend公司的抗MHC class II-APC 抗体,来收集和染色受感染的细胞,进行了流式细胞计量实验。 更多
DDX58
DExD/H-box helicase 58
总数:1
Role of retinoic acid inducible gene-I in human metapneumovirus-induced cellular signalling. 2008 至该文献
为了研究呼由人变性肺病毒引起的吸道上皮细胞的细胞信号转导,采用了ABGENT公司的抗RIG-I抗体进行免疫印迹实验。
DPB1
major histocompatibility complex, class II, DP beta 1
Egr-1
early growth response 1
总数:28
Monocyte 15-lipoxygenase gene expression requires ERK1/2 MAPK activity. 2010 至该文献
为了研究IL-13诱导的单核细胞15-脂氧合酶基因的表达与ERK1/2相关,采用了Santa Cruz Biotechnology的兔抗人Egr-1抗体进行了免疫印迹试验。 更多
EIF4A2
eukaryotic translation initiation factor 4A2
EIF4A3
eukaryotic translation initiation factor 4A3
总数:1
SMG-8 and SMG-9, two novel subunits of the SMG-1 complex, regulate remodeling of the mRNA surveillance complex during nonsense-mediated mRNA decay. 2009 至该文献
为了研究SMG-1激酶在无义介导的mRNA降解过程中的调节机制,采用了ProteinTech公司的eIF4A3抗体,进行了蛋白质印迹实验。
真核生物肽起始因子4e (eIF4E)
eukaryotic translation initiation factor 4E
总数:37
Control of translation and miRNA-dependent repression by a novel poly(A) binding protein, hnRNP-Q. 2013 至该文献
为了研究hnRNP-Q敲减后的蛋白变化,采用BD BioSciences的抗eIF4E抗体进行免疫印迹实验。 更多
EIF4E2
eukaryotic translation initiation factor 4E family member 2
EIF4E3
eukaryotic translation initiation factor 4E family member 3
EIF4G1
eukaryotic translation initiation factor 4 gamma 1
总数:5
Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery. 2010 至该文献
为了研究TDP-43与众多调节RNA代谢的蛋白之间的相互作用,采用Santa Cruz Biotechnology的抗EIF4G抗体进行免疫细胞化学试验。 更多
EIF4G2
eukaryotic translation initiation factor 4 gamma 2
总数:2
eIF4GI links nutrient sensing by mTOR to cell proliferation and inhibition of autophagy. 2008 至该文献
为了研究eIF4GI在调控细胞增殖和自噬中的作用,采用BD Transduction Laboratories公司的鼠抗DAP5抗体产品1:500,进行了免疫印迹实验。 更多
EIF4G3
eukaryotic translation initiation factor 4 gamma 3
ERK1
mitogen-activated protein kinase 3
总数:252
{beta}-Arrestin-2 Mediates Anti-apoptotic Signaling through Regulation of BAD Phosphorylation. 2009 至该文献
为研究BAD蛋白磷酸化在β-Arrestin-2介导的抗凋亡反应中的调控作用,采用了密理博公司的抗ERK1/2多克隆抗体进行免疫印迹和免疫沉淀试验。 更多
FLNB
filamin B
总数:1
Palmitoylation-dependent estrogen receptor alpha membrane localization: regulation by 17beta-estradiol. 2005 至该文献
GBP 5 (GBP 5)
guanylate binding protein 5
总数:1
GBP5 promotes NLRP3 inflammasome assembly and immunity in mammals. 2012 至该文献
为了研究哺乳动物中NLRP3炎性体能被GBP5调控,采用了SantaCruz的山羊抗GBP5抗体进行蛋白印迹实验。
GBP6
guanylate binding protein family member 6
HERC5
HECT and RLD domain containing E3 ubiquitin protein ligase 5
总数:1
An interaction network of the mammalian COP9 signalosome identifies Dda1 as a core subunit of multiple Cul4-based E3 ligases. 2009 至该文献
为了考察E3 ligases中CRL家族的新成员和阐明CRL与CSN相互作用复合物中的新的连接分子,用Santa Cruz 公司的anti-Cyclin E 抗体进行了免疫共沉淀实验.
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
人类白细胞抗原b (HLA B)
major histocompatibility complex, class I, B
总数:1
Fibromodulin as a novel tumor-associated antigen (TAA) in chronic lymphocytic leukemia (CLL), which allows expansion of specific CD8+ autologous T lymphocytes. 2005 至该文献
HLA E (HLA E)
major histocompatibility complex, class I, E
总数:12
ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. 2012 至该文献
为了研究ESCRT-III调控Aurora B介导的细胞脱落,采用了Serotec的FITC标记的抗MHC-I抗体进行流式细胞分选实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-A (HLA-A)
major histocompatibility complex, class I, A
总数:8
Long-term engraftment and expansion of tumor-derived memory T cells following the implantation of non-disrupted pieces of human lung tumor into NOD-scid IL2Rgamma(null) mice. 2008 至该文献
为了研究研究肿瘤和肿瘤基质细胞间的相互作用,采用了Santa Cruz Biotechnology HLA-A(A-18)抗体进行了免疫组化实验。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-C (HLA-C)
major histocompatibility complex, class I, C
总数:7
Identification of major histocompatibility complex class I C molecule as an attachment factor that facilitates coronavirus HKU1 spike-mediated infection. 2009 至该文献
为了研究主要组织相容性复合体作为一种附属因子在促进 HCoV-HKU1 感染过程中的作用,采用英杰的纯化的羊免疫球蛋白作为同型标准品。 更多
HLA-DQB1 (HLA-DQB1)
major histocompatibility complex, class II, DQ beta 1
总数:1
Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma. 2007 至该文献
为了研究CD80和CD86可能作为鼻咽癌预后的标记物,采用Novocastra Laboratories的抗HLA Class II (DR)抗体进行免疫组织化学实验。
HLA-DQB2 (HLA-DQB2)
major histocompatibility complex, class II, DQ beta 2
总数:1
Spontaneous lupus-like syndrome in HLA-DQ2 transgenic mice with a mixed genetic background. 2010 至该文献
为了研究HLA-DQ2在相关的免疫病变病理过程中的作用,采用了Becton Dickinson的抗DQ(TU39)抗体进行流式细胞术。
HLA-DR (HLA-DR)
major histocompatibility complex, class II, DR alpha
总数:22
Tolerance induced via TLR2 and TLR4 in human dendritic cells: role of IRAK-1. 2008 至该文献
为了研究IRAK-1信号阻断对TLR2和TLR4诱导的人树突状细胞耐受有重要作用,采用Beckman-Coulter的抗HLA DR- PC5抗体进行流式细胞分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析,采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析,采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析,采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析,采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析,采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析,采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析,采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析,采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析,采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析,采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB1 (HLA-DRB1)
major histocompatibility complex, class II, DR beta 1
总数:7
Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. 2011 至该文献
为了研究人造血系统细胞给以不同刺激的反应能通过单细胞多因子分选进行分析,采用Biolegend的抗HLADR抗体以2ug/ml浓度进行细胞多因子分选实验。 更多
HLA-DRB5 (HLA-DRB5)
major histocompatibility complex, class II, DR beta 5
总数:2
Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. 2008 至该文献
HLA-DRB5 (HLA-DRB5)
major histocompatibility complex, class II, DR beta 5
总数:2
Microbial translocation is associated with increased monocyte activation and dementia in AIDS patients. 2008 至该文献
HLA-F (HLA-F)
major histocompatibility complex, class I, F
总数:1
Progressive myopathy and defects in the maintenance of myotendinous junctions in mice that lack talin 1 in skeletal muscle. 2008 至该文献
为了研究talin 1在骨骼肌发育和功能中的作用,采用了Sigma的鼠抗MHCf单抗,进行免疫组化实验
ICAM-1 (ICAM-1)
intercellular adhesion molecule 1
总数:30
Remodelling of cortical actin where lytic granules dock at natural killer cell immune synapses revealed by super-resolution microscopy. 2011 至该文献
为了研究在天然杀伤细胞免疫突触处皮质肌动蛋白的重塑,采用了R&D systems的抗ICAM-1抗体进行免疫细胞化学实验。 更多
IFI27
interferon alpha inducible protein 27
IFI6
interferon alpha inducible protein 6
IFIT1
interferon induced protein with tetratricopeptide repeats 1
IFIT2
interferon induced protein with tetratricopeptide repeats 2
IFIT3
interferon induced protein with tetratricopeptide repeats 3
总数:1
Mycobacterial disease and impaired IFN-? immunity in humans with inherited ISG15 deficiency. 2012 至该文献
为了研究人中缺失ISG15损害IFN-gamma免疫并导致分支杆菌易感,采用了BD Biosciences的抗IFIT3抗体进行蛋白印迹实验。
IFITM1
interferon induced transmembrane protein 1
总数:1
Cooperativity of the MUC1 oncoprotein and STAT1 pathway in poor prognosis human breast cancer. 2010 至该文献
为研究MUC1-C和STAT1通路在人类不良预后乳癌中的相互作用,采用了Proteintech Group公司的抗IFITM1抗体进行免疫印迹试验。
IFITM2
interferon induced transmembrane protein 2
IFN丙 (IFN-gamma)
interferon gamma
总数:62
The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence. 2011 至该文献
为了研究血脑屏障的完整性和中枢神经免疫沉默能够被Shh信号通路促进,采用R&D Systems的抗IFN-gamma抗体以5ug/ml浓度进行细胞刺激实验。 更多
IFNA1
interferon alpha 1
总数:11
The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide.. 2010 至该文献
为了研究伊波拉病毒VP35蛋白在调节病毒和脂多糖诱导的树突细胞成熟中的作用,采用了PBL Laboratories公司的抗IFNalpha抗体产品,进行了流式细胞分析实验。 更多
IFNAR1
interferon alpha and beta receptor subunit 1
总数:4
A phosphorylation-acetylation switch regulates STAT1 signaling. 2009 至该文献
为了研究磷酸化-乙酰化开关在调控STAT1信号通路中的作用,采用了Santa Cruz Biotechnology公司的IFNAR1抗体产品,进行了免疫印迹实验。 更多
IFNAR2
interferon alpha and beta receptor subunit 2
总数:4
A phosphorylation-acetylation switch regulates STAT1 signaling. 2009 至该文献
为了研究磷酸化-乙酰化开关在调控STAT1信号通路中的作用,采用了Santa Cruz Biotechnology公司的IFNAR2抗体产品,进行了免疫印迹实验。 更多
IFNB1
interferon beta 1
总数:9
Inhibition of RIG-I and MDA5-dependent antiviral response by gC1qR at mitochondria. 2009 至该文献
IFNGR1
interferon gamma receptor 1
总数:5
Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. 2008 至该文献
为研究人骨髓MSCs表达的TLR3和TLR4对抑制其T细胞调节活性的作用,采用了BD Biosciences公司的抗CD119单克隆抗体进行流式细胞术试验。 更多
IRF-1 (IRF-1)
interferon regulatory factor 1
总数:14
Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes. 2008 至该文献
为研究干扰素调控因子4(IRF-4)在EBV病毒感染人类B淋巴细胞中的作用,采用了Santa Cruz Biotechnology公司的抗IRF-1抗体进行蛋白质印迹试验。 更多
IRF-2 (IRF-2)
interferon regulatory factor 2
总数:7
Interferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytes. 2008 至该文献
为研究干扰素调控因子4(IRF-4)在EBV病毒感染人类B淋巴细胞中的作用,采用了Santa Cruz Biotechnology公司的抗IRF-2抗体进行蛋白质印迹试验。 更多
IRF-3 (IRF-3)
interferon regulatory factor 3
总数:22
DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. 2012 至该文献
为了研究IRF-3依赖的先天性免疫反应,采用了Life Technologies 的抗IRF-3抗体进行了蛋白免疫印迹实验。 更多
IRF4
interferon regulatory factor 4
总数:6
Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma. 2009 至该文献
为从222例症状明显的伯基特淋巴瘤患者中分析其MUM1, bcl-6 和CD138的表达模式与EBV的相关性,将Dako提供的抗MUM-1/IRF4抗体(克隆:MUM1P)用于免疫组织化学实验中。 更多
IRF5
interferon regulatory factor 5
总数:1
Differential requirement of histone acetylase and deacetylase activities for IRF5-mediated proinflammatory cytokine expression. 2010 至该文献
为了说明IRF5同HATs和HDACs一起调控促炎细胞因子的转录水平表达,使用了Abcam公司的山羊抗IRF5多克隆抗体进行免疫共沉淀实验。
IRF6
interferon regulatory factor 6
总数:3
Human ?-defensin 6 promotes mucosal innate immunity through self-assembled peptide nanonets. 2012 至该文献
为了研究粘膜初级免疫受HD6自组装促进,采用了Difco的抗LPS抗体进行免疫细胞化学实验。 更多
IRF7
interferon regulatory factor 7
总数:4
Activation of anti-hepatitis C virus responses via Toll-like receptor 7. 2006 至该文献
为了研究Toll样受体7抵抗丙型肝炎病毒的机制,使用Santa Cruz公司抗IRF-7抗体进行western blot实验。 更多
IRF8
interferon regulatory factor 8
总数:4
IRF-8/interferon (IFN) consensus sequence-binding protein is involved in Toll-like receptor (TLR) signaling and contributes to the cross-talk between TLR and IFN-gamma signaling pathways. 2006 至该文献
IRF9
interferon regulatory factor 9
总数:1
Sendai virus C protein plays a role in restricting PKR activation by limiting the generation of intracellular double-stranded RNA. 2008 至该文献
为了说明SeV C蛋白可以抑制双链RNA的产生来限制PKR的激活,使用了Santa Cruz Biotechnology公司的抗IRF9抗体来进行蛋白印迹实验。
ISG15
ISG15 ubiquitin like modifier
总数:7
Mycobacterial disease and impaired IFN-? immunity in humans with inherited ISG15 deficiency. 2012 至该文献
为了研究人中缺失ISG15损害IFN-gamma免疫并导致分支杆菌易感,采用了Santa Cruz Biotechnology的抗ISG15抗体进行流式细胞筛选和免疫细胞化学实验。 更多
Jak1
Janus kinase 1
总数:22
Identification of human thioredoxin as a novel IFN-gamma-induced factor: mechanism of induction and its role in cytokine production. 2008 至该文献
为了研究thioredoxin是受IFN-gamma诱导的因子并在细胞因子产生过程中起作用,采用Santa Cruz的抗Jak1和抗磷酸化Jak1抗体进行蛋白印迹实验。 更多
Janus激酶2 (Jak2)
Janus kinase 2
总数:34
Covering a broad dynamic range: information processing at the erythropoietin receptor. 2010 至该文献
为了确定在受体信号激活过程中促红细胞生成素受体的受体因素,使用了Upstate公司的抗JAK2抗体来进行免疫沉淀实验和免疫印记分析。 更多
KPNA1
karyopherin subunit alpha 1
总数:1
Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages. 2007 至该文献
KPNA2
karyopherin subunit alpha 2
总数:4
Caldendrin-Jacob: a protein liaison that couples NMDA receptor signalling to the nucleus. 2008 至该文献
KPNA4
karyopherin subunit alpha 4
总数:1
Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages. 2007 至该文献
KPNB1
karyopherin subunit beta 1
总数:7
WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies. 2010 至该文献
为了说明WRAP53是形成卡恰尔身体的必要因素并且能够将SMN复合体定位到卡恰尔身体,使用了Santa Cruz Biotechnology公司的alpha-importin beta鼠抗(sc-137016)来进行免疫印记,免疫沉淀和免疫细胞组化实验。 更多
NEDD4
NEDD4 E3 ubiquitin protein ligase
总数:3
The inositol phosphatase MTMR4 is a novel target of the ubiquitin ligase Nedd4. 2009 至该文献
为了研究Nedd4在肌肉萎缩过程中所起的作用,使用了Upstate公司的抗Nedd4抗体来进行蛋白印迹分析。 更多
核孔蛋白p62 (nucleoporin p62)
nucleoporin 62
总数:8
Fractionation of the Coxiella burnetii parasitophorous vacuole. 2008 至该文献
为了开发一种从宿主细胞材料中分离完整寄生泡的方法,使用了BD Biosciences公司的鼠抗人核膜孔蛋白p62抗体来进行免疫印迹实验。 更多
NUP133
nucleoporin 133
总数:1
The nucleoporin Nup153 has separable roles in both early mitotic progression and the resolution of mitosis. 2009 至该文献
为了研究Nup153在有丝分裂中所起的作用,使用了Covance公司的抗核孔蛋白抗体来进行蛋白印迹分析。
NUP153
nucleoporin 153
总数:2
ESCRT-III governs the Aurora B-mediated abscission checkpoint through CHMP4C. 2012 至该文献
为了研究ESCRT-III调控Aurora B介导的细胞脱落,采用了Abcam的单抗NUP抗体进行蛋白印迹实验。 更多
NUP88
nucleoporin 88
总数:1
Caspases target only two architectural components within the core structure of the nuclear pore complex. 2006 至该文献
OAS1
2'-5'-oligoadenylate synthetase 1
总数:2
A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the antiviral endoribonuclease RNase L. 2007 至该文献
为了研究脊髓灰质炎病毒3C蛋白酶开放阅读框的一个RNA结构的作用,采用Abgent公司的抗OAS1多克隆抗体进行免疫印迹实验。 更多
OAS3
2'-5'-oligoadenylate synthetase 3
PIAS1
protein inhibitor of activated STAT 1
总数:3
Regulation of the SUMO pathway sensitizes differentiating human endometrial stromal cells to progesterone. 2006 至该文献
为了研究cAMP信号介导的小类泛素修饰因子旁路的动态变化决定子宫内膜对孕酮反应的过程,采用了Santa Cruz Biotechnology的抗PIAS1(8152)抗体进行免疫印迹试验。 更多
PIN1
peptidylprolyl cis/trans isomerase, NIMA-interacting 1
总数:2
Phosphorylation of serine 147 of tis21/BTG2/pc3 by p-Erk1/2 induces Pin-1 binding in cytoplasm and cell death. 2005 至该文献
PKC delta
protein kinase C delta
总数:35
PKCalpha tumor suppression in the intestine is associated with transcriptional and translational inhibition of cyclin D1. 2009 至该文献
为了研究在肠部PKCα抑制肿瘤的机制,采用了Santa Cruz Biotechnology公司的抗PKCδ抗体,进行了蛋白质印迹实验。 更多
PKR
eukaryotic translation initiation factor 2 alpha kinase 2
总数:30
The adenovirus E1B 55-kilodalton and E4 open reading frame 6 proteins limit phosphorylation of eIF2alpha during the late phase of infection.. 2009 至该文献
为了研究E1B-55K/E4orf6复合物同eIF2α的关系,采用了Epitomics公司的兔多克隆磷酸化PKR抗体,进行了蛋白印记实验。 更多
血小板活化因子受体 (platelet activating factor receptor)
总数:1
Relative levels of semen platelet activating factor-receptor (PAFr) and ubiquitin in yearling bulls with high content of semen white blood cells: implications for breeding soundness evaluation. 2007 至该文献
为研究血小板活化因子(PAF)受体在生育中的作用,采用Cayman 公司生产的 PAF受体抗体用于免疫印迹和免疫细胞化学实验。
PLC-gamma1 (PLC-gamma1)
phospholipase C gamma 1
总数:32
Phosphatidylinositol-4-phosphate 5-kinase 1alpha mediates extracellular calcium-induced keratinocyte differentiation. 2009 至该文献
为了研究PIP5K1α在胞外钙诱导的第二信使IP3的生成和角质形成细胞分化中的功能,使用了Santa Cruz Biotechnology公司的抗PLCG1多克隆抗体来进行免疫印迹分析和免疫沉淀实验。 更多
前髓细胞性白血病蛋白 (PML)
promyelocytic leukemia
总数:43
The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. 2010 至该文献
为了阐明DAXX作为组蛋白的分子伴侣参与不依赖复制的H3.3组装,采用Santa Cruz Biotechnology的抗PML抗体进行免疫细胞化学实验。 更多
POM121
POM121 transmembrane nucleoporin
PPM1B
protein phosphatase, Mg2+/Mn2+ dependent 1B
总数:1
Role for protein phosphatase 2A in the regulation of Calu-3 epithelial Na+-K+-2Cl-, type 1 co-transport function. 2005 至该文献
PSMB8
proteasome 20S subunit beta 8
总数:3
Immunoproteasome LMP2 60HH variant alters MBP epitope generation and reduces the risk to develop multiple sclerosis in Italian female population. 2010 至该文献
为了研究免疫蛋白酶体在多发性硬化发病机制的作用,采用Affinity-Biomol International抗LMP7抗体进行免疫组织化学试验。 更多
PTPN2
protein tyrosine phosphatase non-receptor type 2
总数:2
MDA5 and PTPN2, two candidate genes for type 1 diabetes, modify pancreatic beta-cell responses to the viral by-product double-stranded RNA. 2010 至该文献
为了研究MDA5 和PTPN2在调节胰岛beta细胞对病毒双链RNA副产物的反应中的作用,采用了R&D Systems公司的抗PTPN2抗体产品,进行了免疫印迹实验。 更多
RAE1
ribonucleic acid export 1
总数:1
The tumorigenicity of mouse embryonic stem cells and in vitro differentiated neuronal cells is controlled by the recipients' immune response. 2008 至该文献
为了研究CCR5在肺纤维细胞的迁移和新陈代谢的促进上的作用,采用了R&D系统公司的抗RAE-1抗体进行了流式细胞实验。
RANBP2
RAN binding protein 2
总数:4
Nitric oxide destabilizes Pias3 and regulates sumoylation. 2007 至该文献
为了研究总的SUMO化水平和Pias3蛋白的稳定性能够被NO调控,采用Santa Cruz的多抗RanBP2抗体进行蛋白印迹实验。 更多
RPS27A
ribosomal protein S27a
总数:5
Ubiquilin and p97/VCP bind erasin, forming a complex involved in ERAD. 2009 至该文献
为了在内质网相关蛋白的降解途径(ERAD)中鉴定一种新的erasin-ubiquilin-p97/VCP复合体以及其功能,使用了Santa Cruz Biotechnology公司的抗体ubiquitin来进行免疫印迹分析。 更多
SHP-1 (SHP-1)
protein tyrosine phosphatase non-receptor type 6
总数:16
The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo. 2009 至该文献
为了说明Lyn能抑制破骨细胞的形成,使用了Santa Cruz Biotechnology公司的SHP-1多克隆抗体进行免疫印迹实验。 更多
SHP-2 (SHP-2)
protein tyrosine phosphatase non-receptor type 11
总数:34
Autoamplification of Notch signaling in macrophages by TLR-induced and RBP-J-dependent induction of Jagged1. 2010 至该文献
为了研究在巨噬细胞中TLR和RBP-J对Notch信号自发放大的调节作用,采用Santa Cruz Biotechnology公司多克隆抗Shp2抗体进行了免疫印迹实验。 更多
SOCS3
suppressor of cytokine signaling 3
总数:10
Unique early gene expression patterns in human adult-to-adult living donor liver grafts compared to deceased donor grafts. 2009 至该文献
为了研究已故捐献者DD)和活人捐献者(LD)肝脏移植在分子水平上的显著差异,采用了Santa Cruz Biotech公司的SOCS3抗体,进行了免疫组织化学实验。 更多
SP100
SP100 nuclear antigen
总数:4
Induction of alternative lengthening of telomeres-associated PML bodies by p53/p21 requires HP1 proteins. 2009 至该文献
为了研究HP1蛋白在p53/p21诱导的端粒酶关联的PML小体的延长中所起的作用,使用了Millipore公司的抗Sp100抗体来进行免疫组化分析。 更多
信号传导子及转录激活子1 (STAT1)
signal transducer and activator of transcription 1
总数:84
T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response. 2010 至该文献
为了研究富于T细胞/组织细胞的B细胞淋巴瘤的基因转录特征,采用了Santa Cruz Biotechnology的抗STAT1抗体进行免疫组织化学实验。 更多
STAT2
signal transducer and activator of transcription 2
总数:11
A phosphorylation-acetylation switch regulates STAT1 signaling. 2009 至该文献
为了研究磷酸化-乙酰化开关在调控STAT1信号通路中的作用,采用了Santa Cruz Biotechnology公司的STAT2抗体产品,进行了免疫印迹实验。 更多
SUMO-1 (SUMO-1)
small ubiquitin like modifier 1
总数:40
A SUMOylation-dependent transcriptional subprogram is required for Myc-driven tumorigenesis. 2012 至该文献
为了研究myc依赖的癌症需要SUMO化修饰来促进肿瘤发生,采用Abcam的抗SUMO1抗体进行蛋白印迹实验。 更多
TPR
translocated promoter region, nuclear basket protein
Tyk2
tyrosine kinase 2
总数:13
Z3, a novel Jak2 tyrosine kinase small-molecule inhibitor that suppresses Jak2-mediated pathologic cell growth. 2008 至该文献
为研究新型酪氨酸激酶JAK-2抑制剂Z3可以抑制JAK-2介导的病理性细胞生长,采用了Santa Cruz 生物技术公司的抗Tyk2和抗磷酸化TyK2多克隆抗体分别进行免疫共沉淀实验和western免疫印迹实验。 。 更多
UBC
ubiquitin C
总数:7
The sphingolipid receptor S1PR2 is a receptor for Nogo-a repressing synaptic plasticity. 2014 至该文献
为了研究突触的可塑性,采用了Enzo Life Sciences的抗Ubiquitin的抗体进行了免疫印迹实验。 更多
UBE2L6
ubiquitin conjugating enzyme E2 L6
总数:1
A phosphorylation-acetylation switch regulates STAT1 signaling. 2009 至该文献
为了研究磷酸化-乙酰化开关在调控STAT1信号通路中的作用,采用了Abgent 公司的UBCH8抗体产品,进行了免疫印迹实验。
UBE2N
ubiquitin conjugating enzyme E2 N
总数:3
A DNA damage response screen identifies RHINO, a 9-1-1 and TopBP1 interacting protein required for ATR signaling. 2011 至该文献
为了研究DNA损伤应答过程中RHINO对ATR活化的重要作用,采用Invitrogen的抗Ubc13抗体进行蛋白印迹实验。 更多
泛肽 (ubiquitin)
ubiquitin B
总数:34
BCL6 degradation caused by the interaction with the C-terminus of pro-HB-EGF induces cyclin D2 expression in gastric cancers. 2009 至该文献
为了阐明BCL6和HB-EGF-CTF相互作用,并且这种相互作用可能会引起细胞周期蛋白D2在人胃癌细胞中表达,采用了Cell Signaling Technology公司的小鼠抗泛素单克隆抗体,进行了蛋白质印迹实验。 更多
USP41
ubiquitin specific peptidase 41
VCAM-1 (VCAM-1)
vascular cell adhesion molecule 1
总数:19
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumour cells by activating the MAPK pathways. 2009 至该文献
为研究前列腺特异膜抗原在前列腺癌细胞的白介素6和CCL5的表达调控中所发挥的角色,将Immunotech提供的抗血管细胞粘附分子抗体用于阻断或激活实验中。 更多